Anbio Biotechnology (NNNN) Retained Earnings (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Retained Earnings of $23.6 million for Q4 2025, up 37.29% year-over-year from $17.2 million in Q4 2024, and down 100.0% quarter-over-quarter from $20971.4 billion in Q2 2025.
Anbio Biotechnology (NNNN) Retained Earnings (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Retained Earnings for 3 consecutive years, with $23.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings rose 37.29% year-over-year to $23.6 million; the TTM figure through Dec 2025 stood at $23.6 million (up 37.29% YoY), while the FY2025 annual figure was $23.6 million, up 37.29% from the prior year.
- Retained Earnings eased to $23.6 million in Q4 2025 per NNNN's latest filing, from $20971.4 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $20971.4 billion in Q2 2025 and bottomed at $14.8 million in Q4 2023.
- Historically, Retained Earnings has averaged $5242.9 billion across 3 years, with a median of $20.4 million in 2024.
- Annual changes were most pronounced in 2024 — Retained Earnings gained 16.03% — and 2025, when it soared 37.29%.
- Anbio Biotechnology's Retained Earnings stood at $14.8 million in 2023, then rose by 16.03% to $17.2 million in 2024, then surged by 37.29% to $23.6 million in 2025.
- Business Quant data shows NNNN's Retained Earnings at $23.6 million in Q4 2025, $20971.4 billion in Q2 2025, and $17.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.69 Bn | 129.47 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.58 Bn | 51.71 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.75 Bn | 34.39 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.89 Bn | 32.42 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 29.13 Bn | 26.45 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.40 Bn | 14.99 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Anbio Biotechnology | 308.32 Mn | 296.42 Mn | - | 23.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.58 Mn |
| Jun 30, 2025 | 20,971.45 Bn |
| Dec 31, 2024 | 17.17 Mn |
| Dec 31, 2023 | 14.80 Mn |